يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Bruzzi, P"', وقت الاستعلام: 1.64s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation

    المؤلفون: Peccatori, J, Barkholt, L, Demirer, T, Sormani, MP, Bruzzi, P, Ciceri, F, Zambelli, A, Da Prada, GA, Pedrazzoli, P, Siena, S, Massenkeil, G, Martino, R, Lenhoff, S, Corradini, P, Rosti, G, Ringden, O, Bregni, M, Niederwieser, D

    المصدر: Cancer. 104(10):2099-2103

    مصطلحات موضوعية: Medicin och hälsovetenskap

    الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:1945879Test

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية
    Survival of metastatic breast carcinoma patients over a 20‐year period: A retrospective analysis based on individual patient data from six consecutive studies

    المؤلفون: Gennari, Alessandra, Conte, PierFranco, Rosso, Riccardo, Orlandini, Cinzia, Bruzzi, Paolo

    المصدر: Cancer; October 2005, Vol. 104 Issue: 8 p1742-1750, 9p

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية
    Concomitant versus sequential administration of epirubicin and paclitaxel as first‐line therapy in metastatic breast carcinomaData presented in part at the 38th American Society of Clinical Oncology Meeting, Orlando, Florida, May 18–21, 2002.: Results from the Gruppo Oncologico Nord Ovest Randomized Trial

    المؤلفون: Conte, Pier Franco, Guarneri, Valentina, Bruzzi, Paolo, Prochilo, Tiziana, Salvadori, Barbara, Bolognesi, Angelo, Aldrighetti, Daniela, Venturini, Marco, Rosso, Riccardo, Mammoliti, Serafina, Carnino, Flavio, Giannessi, Piergiorgio, Costantini, Massimo, Moyano, Alfredo, Baldini, Editta

    المصدر: Cancer; August 2004, Vol. 101 Issue: 4 p704-712, 9p

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية
    Randomized trial comparing cyclophosphamide, methotrexate, and 5–fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinomaPerformed by the Italian Oncology Group for Clinical Research (GOIRC), via Gramsci 14, 43100 Parma, Italy.

    المؤلفون: Cocconi, Giorgio, Blasio, Beatrice Di, Boni, Corrado, Bisagni, Giancarlo, Ceci, Guido, Rondini, Ermanno, Bella, Mariangela, Leonardi, Francesco, Savoldi, Luisa, Camisa, Roberta, Bruzzi, Paolo

    المصدر: Cancer; 15 July 2002, Vol. 95 Issue: 2 p228-235, 8p

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية
    Combined regimen of cisplatin, doxorubicin, and α-2b interferon in the treatment of advanced malignant pleural mesothelioma

    المؤلفون: Parra, Héctor Soto, Tixi, Lucia, Latteri, Fiorenza, Bretti, Sergio, Alloisio, Marco, Gravina, Adriano, Lionetto, Rita, Bruzzi, Paolo, Dani, Carla, Rosso, Riccardo, Cosso, Maurizio, Balzarini, Luca

    المصدر: Cancer; 1 August 2001, Vol. 92 Issue: 3 p650-656, 7p

    النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية
    The unconventional Di Bella cancer treatment

    المؤلفون: Traversa, Giuseppe, Maggini, Marina, Menniti-Ippolito, Francesca, Bruzzi, Paolo, Chiarotti, Flavia, Greco, Donato, Spila-Alegiani, Stefania, Raschetti, Roberto, Benagiano, Giuseppe

    المصدر: Cancer; 15 November 1999, Vol. 86 Issue: 10 p1903-1911, 9p

    النص الكامل

    أضف إلى المفضلة
  7. 7
    Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation

    المؤلفون: Rodrigo Martino, Tanner Demirer, Salvatore Siena, Paolo Pedrazzoli, Paolo Corradini, Gian Antonio Da Prada, Jacopo Peccatori, Lisbeth Barkholt, Paolo Bruzzi, Alberto Zambelli, Olle Ringden, Maria Pia Sormani, Fabio Ciceri, Stig Lenhoff, Gero Massenkeil, Giovanni Rosti, Dietger Niederwieser, Marco Bregni

    المساهمون: Peccatori, J, Barkholt, L, Demirer, T, Sormani, Mp, Bruzzi, P, Ciceri, Fabio, Zambelli, A, Da Prada, Ga, Pedrazzoli, P, Siena, S, Massenkeil, G, Martino, R, Lenhoff, S, Corradini, P, Rosti, G, Ringden, O, Bregni, M, Niederwieser, D.

    المصدر: Cancer. 104:2099-2103

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Allogeneic transplantation, Renal cell carcinoma, Internal medicine, Carcinoma, medicine, Humans, Transplantation, Homologous, Karnofsky Performance Status, Carcinoma, Renal Cell, Survival analysis, Univariate analysis, L-Lactate Dehydrogenase, Performance status, business.industry, Proportional hazards model, Prognosis, medicine.disease, Survival Analysis, Kidney Neoplasms, Surgery, Transplantation, C-Reactive Protein, business, Stem Cell Transplantation

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2368ccd221c1205a90d0b8d4b04e096Test
    https://doi.org/10.1002/cncr.21477Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث